I recognize that there is a body of market participants who worship at the altar of price momentum.
Sometimes, however, when traders and investors blindly follow charts from the lower left to the upper right (hat tip Sir Denny Gartman!), those late to the party get burned, as has been the case recently with the biotech sector.
Read Full Article »